Literature DB >> 16923077

Immune response and protection by DNA vaccines expressing antigen 85B of Mycobacterium tuberculosis.

Manuela Pardini1, Federico Giannoni, Carla Palma, Elisabetta Iona, Aurelio Cafaro, Lara Brunori, Monica Rinaldi, Vito Michele Fazio, Maria Elena Laguardia, Damiano Cosimo Carbonella, Mauro Magnani, Barbara Ensoli, Lanfranco Fattorini, Antonio Cassone.   

Abstract

A plasmid DNA containing two different expression cassettes was prepared to independently drive antigen 85B (85B) of Mycobacterium tuberculosis and HIV-Tat in C57BL/6 mice. In vivo expression of the plasmid was demonstrated by efficient transcription of 85B and Tat mRNAs in mouse fibroblasts. DNA-85B or DNA-(85B-Tat) were immunogenic and protected mice to the same extent against M. tuberculosis infection, with a decrease in the numbers of CFU lung-1 in comparison with nonimmunized animals down to levels (0.64 log10 CFU) not significantly different from protection conferred by bacillus Calmette-Guérin vaccine (0.97 log10 CFU decrease). Multipromoter plasmids, which permit the reduction of the total amount of DNA injected, can be useful for DNA vaccination against tuberculosis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16923077     DOI: 10.1111/j.1574-6968.2006.00390.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  5 in total

1.  Coexpression of PPE 34.9 Antigen of Mycobacterium avium subsp. Paratuberculosis with Murine Interferon Gamma in HeLa Cell Line and Study of Their Immunogenicity in Murine Model.

Authors:  Rajib Deb; P P Goswami
Journal:  Biotechnol Res Int       Date:  2011-02-10

Review 2.  Pharmaceutical aerosols for the treatment and prevention of tuberculosis.

Authors:  Shumaila N M Hanif; Lucila Garcia-Contreras
Journal:  Front Cell Infect Microbiol       Date:  2012-09-07       Impact factor: 5.293

3.  Potential of novel Mycobacterium tuberculosis infection phase-dependent antigens in the diagnosis of TB disease in a high burden setting.

Authors:  Novel N Chegou; Gillian F Black; Andre G Loxton; Kim Stanley; Paulin N Essone; Michel R Klein; Shreemanta K Parida; Stefan H E Kaufmann; T Mark Doherty; Annemieke H Friggen; Kees L Franken; Tom H Ottenhoff; Gerhard Walzl
Journal:  BMC Infect Dis       Date:  2012-01-20       Impact factor: 3.090

4.  Heterologous Immunity between Adenoviruses and Hepatitis C Virus (HCV): Recombinant Adenovirus Vaccine Vectors Containing Antigens from Unrelated Pathogens Induce Cross-Reactive Immunity Against HCV Antigens.

Authors:  Babita Agrawal; Nancy Gupta; Satish Vedi; Shakti Singh; Wen Li; Saurabh Garg; Jie Li; Rakesh Kumar
Journal:  Cells       Date:  2019-05-26       Impact factor: 6.600

5.  Production and Purification of Mycolyl Transferase B of Mycobacterium tuberculosis.

Authors:  Haniyeh Aghababa; Ashraf Mohabati Mobarez; Mehrdad Behmanesh; Nima Khoramabadi; Mandana Mobarhan
Journal:  Tanaffos       Date:  2011
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.